miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.
Pathology - Research and Practice（2019）
摘要
miR-124 suppresses EMT and metastasis via ZEB2. Therefore, miR-124 may represent a potential therapeutic target for TNBC.
更多查看译文
关键词
miR-124,ZEB2,epithelial–mesenchymal transition,Triple-negative breast cancer,Invasion,Metastasis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要